Effects of a nine-strain bacterial synbiotic compared to simethicone in colicky babies – an open-label randomised study
Open Access
- 15 June 2021
- journal article
- research article
- Published by Brill in Beneficial Microbes
- Vol. 12 (3), 249-257
- https://doi.org/10.3920/bm2020.0160
Abstract
The aim of the study was to determine effects of administration of simethicone and a multi-strain synbiotic on the crying behaviour of colicky babies. The study design consisted of an open-label, two parallel treatment group study involving 87 infants aged 3-6 weeks with infantile colic (defined as crying episodes lasting 3 or more hours per day and occurring at least 3 days per week within 3 weeks prior to enrolment) randomly, unequally [1:1.5] assigned to receive simethicone (n=33) or a multi-strain synbiotic (n=54) orally for 4 weeks. The multi-strain synbiotic contained Lactobacillus acidophilus LA-14, Lacticaseibacillus casei R0215, Lacticaseibacillus paracasei Lp-115, Lacticaseibacillus rhamnosus GG, Ligilactobacillus salivarius Ls-33, Bifidobacterium lactis Bl-04, Bifidobacterium bifidum R0071, Bifidobacterium longum R0175 and fructooligosaccharides). Primary outcome measures were the responder rates (effect ≥50% reduction from baseline) of the measures ‘crying days last 3 weeks’, ‘average evening crying duration last 3 weeks’ and ‘reduction of average number of crying phases per day last three weeks’ at the end of treatment. The study is registered at ClinicalTrials.gov under NCT 04487834. Significantly higher responder rates (effect ≥50% reduction from baseline) of the multi-strain synbiotic compared to simethicone were found for the measures ‘crying days last 3 weeks’ (72% vs 18%, PP=0.0001). No significant difference was found for the measure ‘reduction of average number of crying phases per day last three weeks’ (50% vs 42%, P=0.4852). No adverse effects were reported for the two treatment groups. Based on these results, the multi-strain synbiotic can be considered as an interesting therapeutic possibility for the treatment of infantile colic, worthwhile to be investigated further in non-clinical and clinical studies.Keywords
This publication has 47 references indexed in Scilit:
- Probiotics for infantile colic: a systematic reviewBMC Pediatrics, 2013
- 454 Pyrosequencing Analysis on Faecal Samples from a Randomized DBPC Trial of Colicky Infants Treated with Lactobacillus reuteri DSM 17938PLOS ONE, 2013
- Antagonistic effect of Lactobacillus strains against gas-producing coliforms isolated from colicky infantsBMC Microbiology, 2011
- Electronic and Paper Diary Recording of Infant and Caregiver BehaviorsJournal of Developmental & Behavioral Pediatrics, 2010
- Lactobacillus reuteri DSM 17938 in Infantile Colic: A Randomized, Double-Blind, Placebo-Controlled TrialPEDIATRICS, 2010
- Molecular identification of coliform bacteria from colicky breastfed infantsActa Paediatrica, 2009
- Eine Übersicht der therapeutischen Anwendungen von Simethicon in der GastroenterologieSchweizerische Zeitschrift für Ganzheitsmedizin / Swiss Journal of Integrative Medicine, 2007
- Bacterial counts of intestinal Lactobacillus species in infants with colicPediatric Allergy and Immunology, 2005
- Systematic review of the occurrence of infantile colic in the communityArchives of Disease in Childhood, 2001
- Treatment of Infantile Colic with Surface Active Substance (Simethicone)Acta Paediatrica, 1985